matthew_maciejewski

Core Faculty

Matthew Maciejewski, PhD

Contact

mlm34@duke.edu

Focus Areas
Degree

PhD, University of Minnesota

Matt Maciejewski, PhD is a Professor in the Department of Population Health Sciences. He is also a Research Career Scientist and Director of the Health Economics and Policy Unit in the Center for Health Services Research in Primary Care at the Durham VA Medical Center. Matt also holds Adjunct Professor appointments in the Schools of Public Health and Pharmacy at the University of North Carolina at Chapel Hill. Additionally, he has been named a member of the Editorial Board for Health Services Research.

He has research interests in four areas:

1) evaluation of surgical and behavioral interventions for the management of obesity and cardiometabolic conditions
2) evaluation of cost-sharing changes on demand for medications and health services
3) analysis of health care utilization and expenditures in experimental and quasi-experimental studies
4) methods for addressing unobserved confounding in observational studies.

Matt has received funding from NIDA, CMS, AHRQ, VA HSR&D, and the RWJ Foundation. He has published over 190 papers in peer-reviewed journals such as JAMA, JAMA Internal Medicine, JAMA Surgery, Annals of Internal Medicine, Health Economics, Medical Care, Health Services Research, Journal of Clinical Epidemiology and Diabetes Care.

Areas of expertise: Health Services Research, Health Economics, Health Policy, Multimorbidity

From Scholars@Duke

Scholars@Duke Profile
Narayanasamy S, Curtis LH, Hernandez AF, Woods CW, Moody MA, Sulkowski M, et al. Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank. Clin Infect Dis. 2023 Dec 15;77(12):1635–43.

Randell RL, Hornik CP, Curtis L, Hernandez AF, Denwood T, Nebeker C, et al. "Click and mortar" opportunities for digitization and consumerism in trials. Contemp Clin Trials. 2023 Sep;132:107304.

Curtis LH, Sola-Morales O, Heidt J, Saunders-Hastings P, Walsh L, Casso D, et al. Regulatory and HTA Considerations for Development of Real-World Data Derived External Controls. Clin Pharmacol Ther. 2023 Aug;114(2):303–15.